[{"address1": "1065 East Hillsdale Boulevard", "address2": "Suite 100", "city": "Foster City", "state": "CA", "zip": "94404", "country": "United States", "phone": "650 525 5535", "fax": "650 275 4254", "website": "https://www.ternspharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis (MASH); and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity, as well as TERN-800 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.", "fullTimeEmployees": 59, "companyOfficers": [{"maxAge": 1, "name": "Ms. Amy L. Burroughs M.B.A.", "age": 54, "title": "CEO & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1007081, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Melita Sun Jung", "age": 47, "title": "Chief Business Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 508886, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew W. Gengos", "age": 60, "title": "CFO & Head of Corporate Development", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Caryn Gordon McDowell J.D.", "age": 54, "title": "Chief Legal Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Robin  Andrulevich", "age": 58, "title": "Chief People Officer", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeffrey R. Jasper Ph.D.", "title": "Senior Vice President of Research", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Emil T. Kuriakose M.D.", "age": 44, "title": "Chief Medical Officer", "yearBorn": 1980, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott  Harris", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Debra  Sieminski", "title": "Senior Vice President of Medical Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James  Kanter", "title": "Senior VP of CMC", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 4, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 26.11, "open": 25.99, "dayLow": 25.31, "dayHigh": 26.51, "regularMarketPreviousClose": 26.11, "regularMarketOpen": 25.99, "regularMarketDayLow": 25.31, "regularMarketDayHigh": 26.51, "payoutRatio": 0.0, "beta": -0.026, "forwardPE": -18.931656, "volume": 2450418, "regularMarketVolume": 2450418, "averageVolume": 2561840, "averageVolume10days": 3918260, "averageDailyVolume10Day": 3918260, "bid": 26.21, "ask": 26.32, "bidSize": 34, "askSize": 12, "marketCap": 2370449664, "fiftyTwoWeekLow": 1.865, "fiftyTwoWeekHigh": 28.49, "allTimeHigh": 28.49, "allTimeLow": 1.45, "fiftyDayAverage": 12.0321, "twoHundredDayAverage": 6.216775, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2075843456, "profitMargins": 0.0, "floatShares": 61628983, "sharesOutstanding": 90079781, "sharesShort": 10691025, "sharesShortPriorMonth": 8226341, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.122200005, "heldPercentInsiders": 0.0028900001, "heldPercentInstitutions": 0.98517, "shortRatio": 6.48, "shortPercentOfFloat": 0.122200005, "impliedSharesOutstanding": 90079781, "bookValue": 3.246, "priceToBook": 8.106901, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -94435000, "trailingEps": -1.02, "forwardEps": -1.39, "enterpriseToEbitda": -19.162, "52WeekChange": 3.5449052, "SandP52WeekChange": 0.1028198, "quoteType": "EQUITY", "currentPrice": 26.315, "targetHighPrice": 35.0, "targetLowPrice": 17.0, "targetMeanPrice": 28.44444, "targetMedianPrice": 28.0, "recommendationMean": 1.18182, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 9, "totalCash": 295635008, "totalCashPerShare": 3.282, "ebitda": -108331000, "totalDebt": 1029000, "quickRatio": 19.213, "currentRatio": 19.516, "debtToEquity": 0.362, "returnOnAssets": -0.19944, "returnOnEquity": -0.29123, "freeCashflow": -51270876, "operatingCashflow": -77677000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TERN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Terns Pharmaceuticals, Inc.", "longName": "Terns Pharmaceuticals, Inc.", "regularMarketChangePercent": 0.78514, "regularMarketPrice": 26.315, "exchange": "NMS", "messageBoardId": "finmb_558294166", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612535400000, "postMarketChangePercent": 1.6530476, "postMarketPrice": 26.75, "postMarketChange": 0.43499947, "regularMarketChange": 0.205, "regularMarketDayRange": "25.31 - 26.51", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2561840, "fiftyTwoWeekLowChange": 24.45, "fiftyTwoWeekLowChangePercent": 13.10992, "fiftyTwoWeekRange": "1.865 - 28.49", "fiftyTwoWeekHighChange": -2.1749992, "fiftyTwoWeekHighChangePercent": -0.07634255, "fiftyTwoWeekChangePercent": 354.4905, "earningsTimestamp": 1762808400, "earningsTimestampStart": 1762808400, "earningsTimestampEnd": 1762808400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.02, "epsForward": -1.39, "epsCurrentYear": -1.10106, "priceEpsCurrentYear": -23.899696, "fiftyDayAverageChange": 14.282901, "fiftyDayAverageChangePercent": 1.1870663, "twoHundredDayAverageChange": 20.098225, "twoHundredDayAverageChangePercent": 3.232902, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "corporateActions": [], "postMarketTime": 1763772796, "regularMarketTime": 1763758801, "marketState": "CLOSED", "ipoExpectedDate": "2021-02-05", "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "displayName": "Terns Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-11-22"}]